Literature DB >> 25335812

Rheology of red blood cells in patients with HbC disease.

Nathalie Lemonne1, Marie Billaud1, Xavier Waltz2,3,4, Marc Romana2,3, Régine Hierso2,3, Maryse Etienne-Julan1,2, Philippe Connes2,3,5.   

Abstract

Patients with hemoglobin C disease (CC) usually do not develop severe complications in comparison with individuals with sickle cell anemia (SS) or with sickle cell hemoglobin C disease (SC). The present study compared the hematological, biochemical, hemorheological and clinical characteristics of CC patients to those of SS, SC and healthy individuals (AA). Blood viscosity was measured at 225 s(-1) with a cone plate viscometer. The hematocrit-to-blood viscosity ratio (HVR), i.e. an index of red blood cell (RBC) oxygen transport effectiveness, was calculated. RBC deformability was determined at 30 Pa by ektacytometry, and RBC aggregation properties by syllectometry. CC and SC had higher blood viscosity and lower HVR than AA. Nevertheless, HVR was higher in CC compared to SS and tended to be higher than in SC. The CC group exhibited very rigid hyperchromic RBC compared to the three other groups. RBC aggregation abnormalities were observed in CC: low RBC aggregation index and high RBC aggregates strength. Despite these hemorheological abnormalities, CC never had hospitalized painful vaso-occlusive crisis or acute chest syndrome. In contrast, all of them had splenomegaly. Of note, 2 out of 7 CC developed retinopathy or otologic disorders. Whether the blood hyperviscosity and decreased RBC deformability are responsible for these complications is unknown. The higher oxygen transport effectiveness (i.e., HVR) of CC compared to SS is probably at the origin of the very low risk of medical complication in this population.

Entities:  

Keywords:  HbC disease; blood viscosity; red blood cell deformability; sickle cell disease

Mesh:

Year:  2016        PMID: 25335812     DOI: 10.3233/CH-141906

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  7 in total

1.  Influence of feeding hematocrit and perfusion pressure on hematocrit reduction (Fåhraeus effect) in an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  Microcirculation       Date:  2017-11       Impact factor: 2.628

Review 2.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

Review 3.  Physical Properties of Blood and their Relationship to Clinical Conditions.

Authors:  Tamas Alexy; Jon Detterich; Philippe Connes; Kalman Toth; Elie Nader; Peter Kenyeres; Jose Arriola-Montenegro; Pinar Ulker; Michael J Simmonds
Journal:  Front Physiol       Date:  2022-07-06       Impact factor: 4.755

4.  Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study.

Authors:  Bindu Kanathezhath Sathi; Yilin Yoshida; Michael Raymond Weaver; Lila S Nolan; Barbara Gruner; Vinod Balasa; Talissa Altes; Carlos Leiva-Salinas
Journal:  Acta Haematol       Date:  2021-11-08       Impact factor: 3.068

5.  Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.

Authors:  Carly C Ginter Summarell; Vivien A Sheehan
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-17

Review 6.  Sickle cell retinopathy: improving care with a multidisciplinary approach.

Authors:  Farid Menaa; Barkat Ali Khan; Bushra Uzair; Abder Menaa
Journal:  J Multidiscip Healthc       Date:  2017-08-30

7.  An experimental erythrocyte rigidity index (Ri) and its correlations with Transcranial Doppler velocities (TAMMV), Gosling Pulsatility Index PI, hematocrit, hemoglobin concentration and red cell distribution width (RDW).

Authors:  Antonio Valadão Cardoso
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.